8302A/C and (TTA)n polymorphisms in the HMG-CoA reductase gene may be associated with some plasma lipid metabolic phenotypes in patients with coronary heart disease

Lipids

Volumn 39, Issue 3, 2004, Pages 239-241

  Tong, Yu ^a   Zhang, Sizhong ^a   Li, Hai ^b   Su, Zhiguang ^a   Kong, Xiangdong ^a   Liu, Hekun ^a   Xiao, Cuiying ^a   Sun, Yan ^a   Shi, Jia Jun ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; DISEASES; ENZYMES; GENES; METABOLISM;

CORONARY HEART DISEASES (CHR); POLYMORPHISMS; RATE-LIMITING ENZYMES;

LIPIDS;

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ALLELE; ARTICLE; CHINESE; CHOLESTEROL METABOLISM; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; GENE; GENE FUNCTION; GENETIC ASSOCIATION; GENOTYPE; HMGCR GENE; HUMAN; ISCHEMIC HEART DISEASE; LIPID METABOLISM; MAJOR CLINICAL STUDY; NUCLEOTIDE REPEAT; PHENOTYPE;

ASIAN CONTINENTAL ANCESTRY GROUP; CHOLESTEROL, VLDL; CORONARY DISEASE; GENE FREQUENCY; HUMANS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; TRIGLYCERIDES; TRINUCLEOTIDE REPEATS;

EID: 2942628878     PISSN: 00244201     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11745-004-1225-3     Document Type: Article

References (16)

1. Robinson, S.M., and Barker, D.J. (2002) Coronary Heart Disease: A Disorder of Growth, Proc. Nutr. Soc. 61, 537-542.
2. Stephens, J.W., and Humphries, S.E. (2003) The Molecular Genetics of Cardiovascular Disease: Clinical Implications, J. Intern. Med. 253, 120-127.
3. Campos, E., Kotite, L., Blanche, P., Mitsugi, Y., Frost, P.H., Masharani, U., Krauss, R.M., and Havel, R.J. (2002) Properties of Triglyceride-rich and Cholesterol-rich Lipoproteins in the Remnant-like Particle Fraction of Human Blood Plasma, J. Lipid Res. 43, 365-374.
4. Mantel-Teeuwisse, A.K., Verschuren, W.M., Klungel, O.H., Kromhout, D., Lindemans, A.D., Avorn, J., Porsius, A.J., and de Boer, A. (2003) Undertreatment of Hypercholesterolaemia: A Population-Based Study, Br. J. Clin. Pharmacol. 55, 389-397.
5. Gotto, A.M., Jr. (2003) Treating Hypercholesterolemia: Looking Forward, Clin Cardiol. 26 (Suppl. 1), 121-128.
6. Eisenberg, D.A. (1998) Cholesterol Lowering in the Management of Coronary Artery Disease: The Clinical Implications of Recent Trials, Am. J. Med. 28, 53-64.
7. Istvan, E. (2003) Statin Inhibition of HMG-CoA Reductase: A 3-Dimensional View, Atherosclerosis (Suppl.) 4, 3-8.
8. Xydakis, A.M., and Jones, P.H. (2003) Use of Statins for Secondary Prevention, Curr. Treat. Options Cardiovasc. Med. 5, 63-73.
9. Miller, S.A., Dykes, D.D., and Polesky, H.F. (1988) A Simple Salting Out Procedure for Extracting DNA from Human Nucleated Cells, Nucleic Acids Res. 16, 1215.
10. Leitersdorf, E., Hwang, M., and Luskey, K.L. (1990) ScrF1 Polymorphism in the 2nd Intron of the HMGCR Gene, Nucleic Acids Res. 8, 5584.
11. Zuliani, G., and Hobbs, H.H. (1990) A High Frequency of Length Polymorphisms in Repeated Sequences Adjacent to Alu Sequences, Am. J. Hum. Gent. 46, 963-969.
12. Musanti, R., Giorgini, L., Lovisolo, P.P., Pirillo, A., Chiari, A., and Ghiselli, G. (1996) Inhibition of Acyl-CoA: Cholesterol Acyltransferase Decreases Apolipoprotein B-100-Containing Lipoprotein Secretion from HepG2 Cells, J. Lipid Res. 37, 1-14.
13. Miyazaki, A., and Koga, T. (2002) Pravastatin Sodium, an Inhibitor of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase, Decreases Serum Total Cholesterol in Japanese White Rabbits by Two Different Mechanisms, Atherosclerosis 162, 299-306.
14. Maldonado, E.N., Romero, J.R., Ochoa, B., and Aveldano, M.I. (2001) Lipid and Fatty Acid Composition of Canine Lipoproteins, Comp. Biochem. Physiol. B 128, 719-729.
15. Hammad, S.M., Siegel, H.S., and Marks, H.L. (1998) Total Cholesterol, Total Triglycerides, and Cholesterol Distribution Among Lipoproteins as Predictors of Atherosclerosis in Selected Lines of Japanese Quail, Comp. Biochem. Physiol A Integr. Physiol. 119, 485-492.
16. Karpe, F., Hellenius, M.L., and Hamsten, A. (1999) Differences in Postprandial Concentrations of Very-Low-Density Lipoprotein and Chylomicron Remnants Between Normotriglyceridemic and Hypertriglyceridemic Men With and Without Coronary Heart Disease, Metabolism 48, 301-307.